Download FREE Report Sample
Download Free sampleAmyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5 10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
Amyotrophic Lateral Sclerosis Treatment Market contains market size and forecasts of Amyotrophic Lateral Sclerosis (ALS) Treatment in Global, including the following market information:
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Amyotrophic Lateral Sclerosis (ALS) Treatment market was valued at 308.7 million in 2021 and is projected to reach US$ 520.6 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Riluzole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amyotrophic Lateral Sclerosis (ALS) Treatment include Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma and Lunan Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amyotrophic Lateral Sclerosis (ALS) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Percentages, by Type, 2021 (%)
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Percentages, by Application, 2021 (%)
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
